GCA
CBST

Greenwood Capital Associates’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Greenwood Capital Associates’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-3,365
Closed -$223K – 179
2014
Q3 		$223K Buy
3,365
+260
+8% +$17.1K 0.07% 118
2014
Q2 		$217K Buy
+3,105
New +$211K 0.07% 124
2014
Q1 		– Sell
-3,224
Closed -$222K – 153
2013
Q4 		$222K Buy
+3,224
New +$209K 0.07% 103

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Greenwood Capital Associates's CBST Position: Q4 2014 in Review

Greenwood Capital Associates sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 3,365 shares — an estimated $223K sold.

Greenwood Capital Associates first reported a position in CBST in Q4 2013 and held it in 3 quarters. The position peaked at $223K in Q3 2014. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Greenwood Capital Associates reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Greenwood Capital Associates sold 3,365 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $223K.
  • Greenwood Capital Associates first reported a position in CUBIST PHARMACEUTICALS INC in Q4 2013 and held it in 3 quarters.
  • Greenwood Capital Associates's CUBIST PHARMACEUTICALS INC position peaked at $223K in Q3 2014.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Greenwood Capital Associates's 13F filing for Q4 2014, filed 13 Feb 2015.